Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Clinical trial NCT00093704 · TERMINATED
Trial details
- NCT number
- NCT00093704
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.